Drug Report History #68592
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated (Changed) | Updated to: 2019-01-03 | Was: 2018-12-04 |
| Drug Identification Number (Changed) | Updated to: 02390183 | Was: 02448327 |
| Brand name (Changed) | Updated to: ACT EXEMESTANE | Was: ACT DEXTROAMPHETAMINE SR |
| Common or Proper name (Changed) | Updated to: EXEMESTANE | Was: DEXTROAMPHETAMINE |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients (Changed) | Updated to: EXEMESTANE | Was: DEXTROAMPHETAMINE SULFATE |
| Strength(s) (Changed) | Updated to: 25MG | Was: 15MG |
| Dosage form(s) (Changed) | Updated to: TABLET | Was: CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL | ORAL |
| Packaging size (Changed) | Updated to: 30 | Was: 100 |
| Additional packaging sizes | ||
| ATC code (Changed) | Updated to: L02BG | Was: N06BA |
| ATC description (Changed) | Updated to: HORMONE ANTAGONISTS AND RELATED AGENTS | Was: PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2018-12-01 | 2018-12-01 |
| Estimated end date (Changed) | Updated to: 2019-01-20 | Was: 2019-01-28 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |